Axa Capital Surpluse from 2010 to 2025

EQH Stock  USD 54.08  0.70  1.31%   
Axa Equitable's Capital Surpluse is increasing with slightly volatile movements from year to year. Capital Surpluse is predicted to flatten to about 1.8 B. For the period between 2010 and 2025, Axa Equitable, Capital Surpluse quarterly trend regression had mean deviation of  550,841,406 and range of 1.7 B. View All Fundamentals
 
Capital Surpluse  
First Reported
2018-03-31
Previous Quarter
2.3 B
Current Value
2.3 B
Quarterly Volatility
144.1 M
 
Covid
Check Axa Equitable financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Axa Equitable's main balance sheet or income statement drivers, such as Depreciation And Amortization of 545.7 M, Interest Expense of 175.3 M or Selling General Administrative of 2.4 B, as well as many indicators such as Price To Sales Ratio of 0.82, Dividend Yield of 0.0212 or PTB Ratio of 9.94. Axa financial statements analysis is a perfect complement when working with Axa Equitable Valuation or Volatility modules.
  
Check out the analysis of Axa Equitable Correlation against competitors.

Latest Axa Equitable's Capital Surpluse Growth Pattern

Below is the plot of the Capital Surpluse of Axa Equitable Holdings over the last few years. It is Axa Equitable's Capital Surpluse historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Axa Equitable's overall financial position and show how it may be relating to other accounts over time.
Capital Surpluse10 Years Trend
Slightly volatile
   Capital Surpluse   
       Timeline  

Axa Capital Surpluse Regression Statistics

Arithmetic Mean1,548,091,406
Geometric Mean1,437,201,590
Coefficient Of Variation39.22
Mean Deviation550,841,406
Median1,817,612,500
Standard Deviation607,149,844
Sample Variance368630.9T
Range1.7B
R-Value0.89
Mean Square Error83012.5T
R-Squared0.79
Slope113,335,643
Total Sum of Squares5529464T

Axa Capital Surpluse History

20251.8 B
20242.6 B
20222.3 B
20211.9 B
2020B
20191.9 B
20181.9 B

About Axa Equitable Financial Statements

Investors use fundamental indicators, such as Axa Equitable's Capital Surpluse, to determine how well the company is positioned to perform in the future. Although Axa Equitable's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Capital Surpluse2.6 B1.8 B

Currently Active Assets on Macroaxis

When determining whether Axa Equitable Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Axa Equitable's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Axa Equitable Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Axa Equitable Holdings Stock:
Check out the analysis of Axa Equitable Correlation against competitors.
You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Is Diversified Financial Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Axa Equitable. If investors know Axa will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Axa Equitable listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.40)
Dividend Share
0.96
Earnings Share
3.78
Revenue Per Share
38.72
Quarterly Revenue Growth
0.946
The market value of Axa Equitable Holdings is measured differently than its book value, which is the value of Axa that is recorded on the company's balance sheet. Investors also form their own opinion of Axa Equitable's value that differs from its market value or its book value, called intrinsic value, which is Axa Equitable's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Axa Equitable's market value can be influenced by many factors that don't directly affect Axa Equitable's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Axa Equitable's value and its price as these two are different measures arrived at by different means. Investors typically determine if Axa Equitable is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Axa Equitable's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.